A
Atossa Therapeutics (ATOS)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Atossa Therapeutics (ATOS)
Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing medicines in areas of unmet medical need in oncology with a focus on breast cancer. The Company’s lead drug candidate under development is oral (Z)-endoxifen, which th... Read more
- USD0.79
- USD0.90
- USD0.78
- USD1.66
- -13.50%
- --
- 888.44k
- 754.20k
- 100M
- 0.55
- -40.20%
Stock News
yesterday
Trump ‘revenge tax’ may open new front in global trade war, with consequences for your wallet
MarketWatch
yesterday
Robinhood's $200 million Bitstamp deal takes it beyond retail trading
CNBC
yesterday
CEO trusted by Jay-Z, Google exec says 'conflict' is the key to success: 'It's OK to disagree'
CNBC
yesterday
Bristol Myers' new cancer partnership is promising, but doesn't change our stance on the stock yet
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
